Subscribe to Search results

Paul Winstanley wrote to J Brown about the use of blood from prisons. It was noted that it was for individual regional transfusion directors to determine this issue, and that the Home Office had been very much in favour of blood donation by prisoners.

Published on:

Dr Tony Napier told the Inquiry that encouraging prisoners to donate was thought to help their rehabilitation.

Published on:

The South West Regional Transfusion Centre stopped collecting donations from prisons.

Published on:

Dr John Wallace, the senior Scottish National Blood Transfusion Service director, stated in "Blood Transfusion for Clinicians" that it was socially and psychologically undesirable to exclude prisoners from blood donation.

Published on:

Scottish National Blood Transfusion Service directors considered the collection of blood in prisons and borstals. The meeting did not agree on future policy.

Published on:

Dr Brookes reported to Scottish National Blood Transfusion Service directors her consultation with the English/Welsh transfusion directors concerning collections in prisons and borstals.

Published on:

Belfast held its last prison donor session at HMP Belfast (Crumlin Road Jail), Magilligan HM Prison, Limavady, Co Londonderry.

Published on:

In his oral evidence to the Inquiry, Dr Morris McClelland acknowledged that there was an argument that prison donations in Northern Ireland should have been stopped long before October 1983.

Published on:

In his oral evidence, Dr Morris McClelland stated that the armed forces sessions in Northern Ireland were a valuable source of donors at a time when the blood services were struggling to maintain blood supplies.

Published on:

Dr Morris McClelland told the Inquiry that he was aware that there was a higher incidence of Hepatitis B among military donors, but given how important these donors were, he was unsure how much consideration he would have given to this.

Published on:

Dr Morris McClelland explained that if a donor session was held at a factory or a workplace, they would have many more donors than if it were held in other community locations.

Published on:

Dr Morris McClelland told the Inquiry that policies adopted in London were followed by the Northern Ireland Blood Transfusion Service.

Published on:

According to Dr Morris McClelland's recollection, measures to prevent those with a history of intravenous drug use from giving blood included an interview and general assessment, but not anything more specific.

Published on:

Dr Morris McClelland told the Inquiry that the rapid uptake of red cell concentrates from 20% of the Belfast output to 75-80% in the space of three to four years was testament to the success of his and Dr Bharucha's work in persuading colleagues to use less whole blood and more red cell concentrates.

Published on:

In his evidence to the Inquiry, Dr Morris McClelland said that had they been asked, the Northern Ireland Blood Transfusion Service would have been able to reprioritise and increase cryoprecipitate production. However, no such request was made.

Published on:

Dr Morris McClelland told the Inquiry that he did not consider it to be his place to question the prescribing practice of Dr Elizabeth Mayne, the Belfast haemophilia director.

Published on:

An article in The British Medical Journal discussed how a recent outbreak of hepatitis after prophylactic serum aroused controversy and drew attention to the dangers of hepatitis associated with immunisation.

Published on:

A study by Feinstone et al identified infectious hepatitis as Hepatitis A in 1973.

Published on:

Findlay and MacCallum considered cases of hepatitis following yellow fever vaccination, the possible explanations for this and considered whether a virus capable of producing jaundice in humans was capable of being the source.

Published on:

The Scottish National Report for 1973 stated that routine screening of all donated blood for the presence of hepatitis-associated antigen had been in place for a year or longer in some centres.

Published on: